Clin2
NCT05335083Possibly a fitNot yet recruiting

Sleep and glucose study for adults with sleep apnea

Obstructive Sleep ApneaPre-diabetes

Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing clinical trials.

This study checks how stopping CPAP treatment for a short time affects glucose levels in people with sleep apnea who do not have diabetes. It may help find out if sleep apnea is linked to blood sugar problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old and live in the community, not in a care facility.
  • You have been diagnosed with moderate to severe sleep apnea in the last 5 years.
  • You are not diabetic (blood sugar tests within the last 3 months show normal levels).
  • You can use a smartphone to download a sleep tracking app.
  • You are willing to temporarily stop using your CPAP machine for part of the study.
  • You are able to read and understand English.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05539716Recruiting
Treating sleep apnea to study effects on metabolism

This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.

Miami, Florida
NCT06825923Not yet recruiting
Personalized treatment for newly diagnosed sleep apnea

This study looks at different types of sleep apnea to find the best treatment for each person. If you are newly diagnosed and haven't tried CPAP yet, your participation could help doctors personalize therapy for better results.

Nanjing, Jiangsu
NCT06319482Recruiting
Testing a new sleep apnea therapy device

This study tests a new proactive therapy for people recently diagnosed with moderate or severe sleep apnea. It aims to see how well patients stick with the treatment outside of a sleep lab.

Halifax, Nova Scotia
NCT05558501Recruiting· Phase 1/Phase 2
Intermittent low-oxygen therapy for sleep apnea and health risks

This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.

Detroit, Michigan
NCT07723144Recruiting
Identifying sleep apnea biomarkers

This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.

Bialystok, Podlaskie Voivodeship
NCT06381115Recruiting
SleepWell24 app for new CPAP users

This study tests a smartphone app called SleepWell24 to help people with newly diagnosed sleep apnea stick with their CPAP therapy and improve their quality of life.

Scottsdale, Arizona

Hear when a new Obstructive Sleep Apnea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.